Cargando…
Interferon-α-Induced Dendritic Cells Generated with Human Platelet Lysate Exhibit Elevated Antigen Presenting Ability to Cytotoxic T Lymphocytes
Given the recent advancements of immune checkpoint inhibitors, there is considerable interest in cancer immunotherapy provided through dendritic cell (DC)-based vaccination. Although many studies have been conducted to determine the potency of DC vaccines against cancer, the clinical outcomes are no...
Autores principales: | Date, Ippei, Koya, Terutsugu, Sakamoto, Takuya, Togi, Misa, Kawaguchi, Haruhiko, Watanabe, Asuka, Kato, Tomohisa, Shimodaira, Shigetaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823331/ https://www.ncbi.nlm.nih.gov/pubmed/33374342 http://dx.doi.org/10.3390/vaccines9010010 |
Ejemplares similares
-
Quality Verification with a Cluster−Controlled Manufacturing System to Generate Monocyte−Derived Dendritic Cells
por: Kawaguchi, Haruhiko, et al.
Publicado: (2021) -
Dendritic Cells Pre-Pulsed with Wilms’ Tumor 1 in Optimized Culture for Cancer Vaccination
por: Koya, Terutsugu, et al.
Publicado: (2020) -
Different In Vitro-Generated MUTZ-3-Derived Dendritic Cell Types Secrete Dexosomes with Distinct Phenotypes and Antigen Presentation Potencies
por: Sakamoto, Takuya, et al.
Publicado: (2022) -
Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity
por: Koya, Terutsugu, et al.
Publicado: (2017) -
In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination
por: Shimodaira, Shigetaka, et al.
Publicado: (2019)